CT Contrast

Naval Medical Center Camp Lejeune, North Carolina, required an urgent three-month supply of CT contrast agent to address a critical supply chain disruption caused by a manufacturer recall that began in March 2026. The Defense Health Agency, operating under the Department of Defense and based in Frederick, Maryland, initiated a sole-source procurement under the justification of unusual and compelling urgency, as allowed by FAR 6.302-2, to ensure uninterrupted diagnostic imaging services vital to patient and warfighter safety. The contract was awarded to Tri-Pharma, Inc., identified as the only viable supplier capable of delivering the required product in time to prevent life-threatening delays in care. The procurement, identified by solicitation number HT940626PE073 and NAICS code 325412 for pharmaceutical preparation manufacturing, carries an estimated product delivery to the medical center’s location in Camp Lejeune with no formal contract value disclosed, indicating the document reflects a pre-award justification rather than a fully executed financial agreement. The acquisition is classified as a small business procurement with Tri-Pharma, Inc. holding a UEI of P2EDVGEMMDB3 and a CAGE code of 5UXG1, affirming its small business status under the SBA’s 1,300-employee threshold for this NAICS code. No formal evaluation factors, weighted criteria, or competitive bidding process was applied due to the non-competitive nature of the award. Acceptance of the product is implied to occur at the destination in Camp Lejeune under federal medical product standards, though specific inspection protocols or packaging specifications such as MIL-STDs are not detailed. Funding is associated with agency code HT9406 and product/service code 6515, but payment office details, invoicing method, and contracting officer information are not specified. The urgency of the requirement overrides standard administrative protocols, and the procurement is structured to restore clinical operations immediately, with no contract options, key personnel clauses, security clearances, or OCI provisions included. The procurement was posted on SAM.gov on July 7, 2026, with Gerrie Johnson as the primary point of contact, and reflects a high-risk scenario with direct implications for medical readiness, patient safety, and operational continuity in a military healthcare environment.